Maturation of nasal microbiota and antibiotic exposures during early childhood: a population-based cohort study

Y Raita1, L Toivonen2, L Schuez-Havupalo3

  • 1Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114-1101, USA.

Insights

The nasal microbiota of healthy children matures in the first two years, with specific bacterial genera changing with age. Early antibiotic exposure alters this development, impacting the types of bacteria present.

Area of Science:

  • Microbiology
  • Pediatrics
  • Computational Biology

Background:

  • The development of the airway microbiota in early childhood is not well understood.
  • Early-life antibiotic exposure may significantly impact microbial development.

Purpose of the Study:

  • To investigate the maturation of the nasal microbiota in the first 24 months of life.
  • To examine the influence of early-life antibiotic exposure on nasal microbiota development.

Main Methods:

  • A population-based birth cohort of 902 healthy Finnish children was studied.
  • Deep neural network models were used to analyze nasal microbiota composition (16S rRNA gene sequencing) in relation to child age.
  • Stratified analyses were performed based on antibiotic exposure during the first two months of life.

Main Results:

  • Deep neural networks successfully modeled the relationship between bacterial genera and child age.
  • Specific genera like Staphylococcus and Corynebacteriaceae decreased with age, while Dolosigranulum and Moraxella increased.
  • Early antibiotic exposure was associated with an increase in Haemophilus, whereas Dolosigranulum increased in unexposed children.

Conclusions:

  • The study demonstrates significant maturation of the nasal microbiota in healthy children during the first two years of life.
  • Early infant antibiotic exposure is linked to distinct age-discriminatory bacteria in the nasal microbiota.
Abstract